Best Approaches to Switching Therapies for a Patient With Myelofibrosis

Opinion
Video

Reasons to switch JAK inhibitors include worsening blood counts and insufficient symptom or spleen response at maximum doses, with the goal of avoiding gaps in treatment by stopping one JAK inhibitor when ready to start the next to prevent symptom rebound while still allowing for potential increased efficacy from an alternative mechanism of action.

Recent Videos
Image of a woman in front of a blue Oncology Nursing News-branded backdrop.
Smiling woman in front of a blue video call background with logos that say "All in Against Cancer" and "Ochsner Health" above her
Related Content